Assignee
DEUTERX LLC
US·20 granted patents·20 pending applications·225 citations·filing 2012–2025
Top patents by PatentIndex Score
40 records- 0198US9732031B2Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropionDEUTERX LLC·Filed 2014·Granted Aug 15, 2017·121 cites·9 claims
- 0296US11535603B1Deuterium-enriched piperidinonyl-oxoisoindolinyl acetamides and methods of treating medical disorders using sameDEUTERX LLC·Filed 2020·Granted Dec 27, 2022·4 cites·15 claims
- 0395US9833445B25-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2016·Granted Dec 5, 2017·12 cites·42 claims
- 0495US9809603B1Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using sameDEUTERX LLC·Filed 2016·Granted Nov 7, 2017·12 cites·22 claims
- 0595US9416117B25-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2015·Granted Aug 16, 2016·12 cites·35 claims
- 0695US9290475B23-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2014·Granted Mar 22, 2016·10 cites·31 claims
- 0795US8969581B25-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2014·Granted Mar 3, 2015·19 cites·31 claims
- 0892US9540340B23-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2014·Granted Jan 10, 2017·12 cites·4 claims
- 0991US9925175B2Deuterium-enriched pioglitazoneDEUTERX LLC·Filed 2016·Granted Mar 27, 2018·7 cites·10 claims
- 1090US2025302838A13-(substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2024·Application pending·0 cites
- 1187US10202316B23-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2016·Granted Feb 12, 2019·4 cites·18 claims
- 1286US10189858B2Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using sameDEUTERX LLC·Filed 2017·Granted Jan 29, 2019·3 cites·20 claims
- 1385US12180137B1Solid forms of enantiopure deuterium-enriched bupropion and methods of use thereofDEUTERX LLC·Filed 2024·Granted Dec 31, 2024·0 cites·15 claims
- 1485US2026085033A1Solid forms of enantiopure deuterium-enriched bupropion and methods of use thereofDEUTERX LLC·Filed 2025·Application pending·0 cites
- 1583US10188639B2Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazoneDEUTERX LLC·Filed 2015·Granted Jan 29, 2019·3 cites·20 claims
- 1683US8735454B2Deuterium-enriched bupropionDEUTERX LLC·Filed 2013·Granted May 27, 2014·4 cites·22 claims
- 1783US2023277539A13-(substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2022·Application pending·0 cites
- 1882US2024417368A1Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropionDEUTERX LLC·Filed 2024·Application pending·0 cites
- 1980US2025320192A1Deuterium-enriched piperidinonyl-oxoisoindolinyl acetamides and methods of treating medical disorders using sameDEUTERX LLC·Filed 2024·Application pending·0 cites
- 2078US9913845B23-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2016·Granted Mar 13, 2018·1 cites·20 claims
- 2178US2022213023A1Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropionDEUTERX LLC·Filed 2022·Application pending·0 cites
- 2276US11820720B23-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deuteropiperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2021·Granted Nov 21, 2023·0 cites·10 claims
- 2376US2023242504A1Deuterium-enriched piperidinonyl-oxoisoindolinyl acetamides and methods of treating medical disorders using sameDEUTERX LLC·Filed 2022·Application pending·0 cites
- 2475US8669275B2Deuterium-enriched donepezilDEUTERX LLC·Filed 2012·Granted Mar 11, 2014·1 cites·15 claims
- 2574US11491156B23-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2019·Granted Nov 8, 2022·0 cites·14 claims
- 2674US2023218595A1Combination therapy using enantiopure, oxy-substituted, deuterium-enriched 5-(benzyl)-5-deutero-thiazolidine-2,4-diones for treatment of medical disordersDEUTERX LLC·Filed 2022·Application pending·0 cites
- 2773US2021387940A1Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropionDEUTERX LLC·Filed 2021·Application pending·0 cites
- 2871US10555946B23-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2017·Granted Feb 11, 2020·0 cites·22 claims
- 2969US11040925B23-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2018·Granted Jun 22, 2021·0 cites·17 claims
- 3065US2014243377A1Deuterium-enriched pioglitazoneDEUTERX LLC·Filed 2014·Application pending·0 cites
- 3161US2018327379A12',6'-dioxo-3'-deutero-piperdin-3-yl-isoindoline compoundsDEUTERX LLC·Filed 2018·Application pending·0 cites
- 3260US2014329851A1Deuterium-enriched prasugrelDEUTERX LLC·Filed 2014·Application pending·0 cites
- 3360US2017369420A1Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropionDEUTERX LLC·Filed 2017·Application pending·0 cites
- 3460US2018125827A15-deutero-thiazolidine-2,4-dione compounds and methods of treating medical disorders using sameDEUTERX LLC·Filed 2017·Application pending·0 cites
- 3559US2018118712A12',6'-dioxo-3'-deutero-piperdin-3-yl-isoindoline compoundsDEUTERX LLC·Filed 2017·Application pending·0 cites
- 3654US2018117026A1Combination therapy using enantiopure, oxy-substituted, deuterium-enriched 5-(benzyl)-5-deutero-thiazolidine-2,4-diones for treatment of medical disordersDEUTERX LLC·Filed 2017·Application pending·0 cites
- 3752US2016002202A12',6'-dioxo-3'-deutero-piperdin-3-yl-isoindoline compoundsDEUTERX LLC·Filed 2015·Application pending·0 cites
- 3852US2018118730A15-deutero-thiazolidinyldione compounds and methods of treating medical disorders using sameDEUTERX LLC·Filed 2017·Application pending·0 cites
- 3947US2014221369A15-deutero-2,4-thiazolidinedione and 5-deutero-2,4-oxazolidinedione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2014·Application pending·0 cites
- 4042US2018125834A1Methods of treating bacterial infections and fungal infections using enantiopure deuterium-enriched pioglitazoneDEUTERX LLC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DEUTERX LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →